Envarsus XR® pharmacokinetics in adolescents post‐kidney transplantation – A pilot study
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric Transplantation"
DOI: 10.1111/petr.14480
Abstract: Envarsus XR® (LCPT), a once daily dosage formulation of tacrolimus, is an FDA‐approved medication in adult renal transplant recipients (RTRs). There are limited data on its pharmacokinetics (PK) in adolescent RTRs. We report here the… read more here.
Keywords: post kidney; adolescents post; envarsus; transplantation ... See more keywords